JP2005525128A5 - - Google Patents

Download PDF

Info

Publication number
JP2005525128A5
JP2005525128A5 JP2004530731A JP2004530731A JP2005525128A5 JP 2005525128 A5 JP2005525128 A5 JP 2005525128A5 JP 2004530731 A JP2004530731 A JP 2004530731A JP 2004530731 A JP2004530731 A JP 2004530731A JP 2005525128 A5 JP2005525128 A5 JP 2005525128A5
Authority
JP
Japan
Prior art keywords
seq
tcr
vector
cloned
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004530731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005525128A (ja
JP4447456B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/017785 external-priority patent/WO2004018619A2/en
Publication of JP2005525128A publication Critical patent/JP2005525128A/ja
Publication of JP2005525128A5 publication Critical patent/JP2005525128A5/ja
Application granted granted Critical
Publication of JP4447456B2 publication Critical patent/JP4447456B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004530731A 2001-06-05 2002-06-05 P53結合t細胞受容体分子とその使用 Expired - Lifetime JP4447456B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29632401P 2001-06-05 2001-06-05
PCT/US2002/017785 WO2004018619A2 (en) 2001-06-05 2002-06-05 P53 binding t cell receptor molecules and uses thereof

Publications (3)

Publication Number Publication Date
JP2005525128A JP2005525128A (ja) 2005-08-25
JP2005525128A5 true JP2005525128A5 (enExample) 2006-01-05
JP4447456B2 JP4447456B2 (ja) 2010-04-07

Family

ID=31946570

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004530731A Expired - Lifetime JP4447456B2 (ja) 2001-06-05 2002-06-05 P53結合t細胞受容体分子とその使用

Country Status (11)

Country Link
US (1) US7456263B2 (enExample)
EP (2) EP1546188B1 (enExample)
JP (1) JP4447456B2 (enExample)
CN (1) CN1692124B (enExample)
AT (1) ATE405582T1 (enExample)
AU (1) AU2002316190B8 (enExample)
CA (1) CA2487779C (enExample)
DE (1) DE60228504D1 (enExample)
DK (1) DK1546188T3 (enExample)
ES (1) ES2307770T3 (enExample)
WO (1) WO2004018619A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2322228B1 (en) * 2000-06-05 2018-01-10 Altor BioScience Corporation T cell receptor fusion proteins and conjugates and methods of use thereof
KR101131297B1 (ko) 2003-11-10 2012-03-30 알토 바이오사이언스 코포레이션 가용성 티씨알 분자 및 이용 방법
WO2006036445A2 (en) 2004-09-24 2006-04-06 Trustees Of Dartmouth College Chimeric nk receptor and methods for treating cancer
WO2011044186A1 (en) 2009-10-06 2011-04-14 The Board Of Trustees Of The University Of Illinois Human single-chain t cell receptors
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
US12492376B2 (en) 2009-10-29 2025-12-09 The Trustees Of Dartmouth College T-cell receptor-deficient T cell compositions
US9833476B2 (en) 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
CN104395344B (zh) 2012-05-07 2019-08-13 达特茅斯大学理事会 抗b7-h6抗体、融合蛋白及其使用方法
UA114108C2 (uk) 2012-07-10 2017-04-25 Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
IL273515B2 (en) * 2017-09-29 2026-03-01 Us Health T cell receptors that recognize mutated P53
WO2019069125A1 (en) 2017-10-06 2019-04-11 Oslo Universitetssykehus Hf CHIMERIC ANTIGEN RECEPTORS
CN108060135A (zh) * 2017-12-26 2018-05-22 东莞赛尔生物科技有限公司 一种高效表达p53抑癌蛋白的t细胞、制备方法及应用
CA3096202A1 (en) 2018-04-06 2019-10-10 The Regents Of The University Of California Methods of treating egfrviii expressing glioblastomas
EP3773633A4 (en) 2018-04-06 2022-01-26 The Regents of The University of California METHODS OF TREATMENT OF GLIOBLASTOMA

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867973A (en) 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
WO1988007553A1 (fr) 1987-03-26 1988-10-06 Teijin Limited Procede de preparation d'un complexe d'anticorps
CA2076347C (en) 1990-02-20 1996-11-26 Ravinder K. Gupta Improved antibody-enzyme direct conjugates and method of making same
GB9200417D0 (en) 1992-01-09 1992-02-26 Bagshawe Kenneth D Cytotoxic drug therapy
US6399368B1 (en) 1992-01-17 2002-06-04 Board Of Regents, The University Of Texas System Secretion of T cell receptor fragments from recombinant Escherichia coli cells
CA2136624A1 (en) * 1992-05-26 1993-12-09 Cornelis J. M. Melief Peptides of human p53 protein for use in human t cell response inducing compositions, and human p53 protein-specific cytotoxic t-lymphocytes
WO1994012520A1 (en) 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
DK0776339T4 (da) 1994-07-29 2010-05-25 Sunol Molecular Corp MHC-komplekser og anvendelser deraf
WO1996013593A2 (en) 1994-10-26 1996-05-09 Procept, Inc. Soluble single chain t cell receptors
AU712441B2 (en) * 1994-12-14 1999-11-04 Scripps Research Institute, The In vivo activation of tumor-specific cytotoxic T cells
US5830755A (en) 1995-03-27 1998-11-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services T-cell receptors and their use in therapeutic and diagnostic methods
US5869270A (en) 1996-01-31 1999-02-09 Sunol Molecular Corporation Single chain MHC complexes and uses thereof
EP0910409A4 (en) 1996-03-05 2003-03-19 Scripps Research Inst RECOMBINANT GENE CONSTRUCTS ENCODING T-CELL RECEPTORS SPECIFIC TO HUMAN-RESTRICTED TUMORANTANTIGENS
US6127524A (en) 1996-10-18 2000-10-03 Dade Behring Inc. Binding molecules and computer-based methods of increasing the binding affinity thereof
WO1998039482A1 (en) 1997-03-07 1998-09-11 Sunol Molecular Corporation Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor
CA2305630C (en) 1997-10-02 2012-11-06 Sunol Molecular Corporation Soluble single-chain t-cell receptor proteins
EP1124568B1 (en) 1998-10-21 2007-08-22 Altor BioScience Corporation Polyspecific binding molecules and uses thereof
CN1430728A (zh) 2000-05-25 2003-07-16 苏诺尔分子公司 T细胞受体交互作用的调节
EP2322228B1 (en) 2000-06-05 2018-01-10 Altor BioScience Corporation T cell receptor fusion proteins and conjugates and methods of use thereof
DE10109855A1 (de) * 2001-03-01 2002-09-12 Stanislawski Thomas Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung

Similar Documents

Publication Publication Date Title
Brierley et al. Mutational analysis of the “slippery-sequence” component of a coronavirus ribosomal frameshifting signal
Stemmer et al. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides
Ivanoff et al. Expression and site-specific mutagenesis of the poliovirus 3C protease in Escherichia coli.
Fett et al. The primary structure of human glutaminyl-tRNA synthetase. A highly conserved core, amino acid repeat regions, and homologies with translation elongation factors
JP2005514927A5 (enExample)
KR20010071613A (ko) 매우 다양한 라이브러리의 생산방법
JP2004511201A5 (enExample)
CN104379748B (zh) L-核酸的酶促合成
FR2480781A1 (fr) Expression de polypeptide bacterien dans laquelle on emploie un promoteur/operateur de tryptophanne
AU3798393A (en) Exchangeable template reaction
EP1527173A1 (en) Gene shuffing by template switching
MXPA03006344A (es) Montaje dirigido por computadora de un polinucleotido que codifica un polipeptido objetivo.
JP2001512666A5 (enExample)
CN106467910A (zh) L-dna/l-rna聚合酶及其应用
KR20160079126A (ko) 효소를 통한 l-핵산의 합성
JPH10511554A (ja) 所望のペプチド混合物をコードするポリヌクレオチド混合物の制御された合成法
BR9915969A (pt) Toxinas pesticidas e seq ências de nucleotìdeos que codificam estas toxinas
CN110747191A (zh) 多肽、嵌合聚合酶及其应用
US20030027194A1 (en) Modular assembly of nucleic acid-protein fusion multimers
WO2002040664A1 (fr) Procede de construction d'une bibliotheque d'acides nucleiques
JP3415995B2 (ja) 高分子マイクロ遺伝子重合体の作成方法
Nashimoto 3'truncated tRNAArg is essential for in vitro specific cleavage of partially synthesized mouse 18S rRNA
Henry et al. Purification and Biochemical Characterization of the 19-kDa Signal Recognition Particle RNA-Binding Protein Expressed as a Hexahistidine-Tagged Polypeptide inEscherichia coli
ATE458037T1 (de) Grosstechnisch geeigneter mikroorganismus
JP3277523B2 (ja) 因子XaリンカーDNA